ABI-007 (Abraxane, nab-paclitaxel)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for ABI-007 (Abraxane, nab-paclitaxel), covering 2013-07-02 to 2013-07-02. Get the full timeline:
Most recent: Clinical Trial Update: Phase II Trial Comparing ABI-007 (Abraxane®, Nab®-Paclitaxel) to Taxotere in First Line Therapy of Patients With Stage IV Breast Cancer [Phase 2]